Atrion Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATRI research report →
Price Chart
About the company
Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure.
- CEO
- David A. Battat
- IPO
- 1980
- Employees
- 712
- HQ
- Allen, TX, US
Get TickerSpark's AI analysis on ATRI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $809.44M
- P/E
- 41.74
- PEG
- -0.78
- P/S
- 4.78
- P/B
- 3.33
- EV/EBITDA
- 21.40
- Div Yield
- 1.91%
- Gross Margin
- 36.84%
- Op Margin
- 13.33%
- Net Margin
- 11.46%
- ROE
- 8.05%
- ROIC
- 7.89%
Latest fiscal year · YoY change
- Revenue
- $169.33M-7.7%
- Gross Profit
- $62.39M-17.8%
- Op Income
- $22.58M
- Net Income
- $19.41M-44.6%
- EPS
- $11.02-43.7%
- OCF Growth
- -30.5%
- FCF Growth
- +53.2%
- 52W High
- $503.24
- 52W Low
- $274.98
- 50D MA
- $455.95
- 200D MA
- $400.15
- Beta
- 0.69
- RSI (14)
- 64
- Avg Volume
- 27.59K
No earnings-call transcripts are available for ATRI yet.
- Free Float
- 93.5%
- Shares Outstanding
- 1.76M
- Float Shares
- 1.65M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.44. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock Inc. | 108.49K | ▲ 4.44K |
| Credit Suisse AG/ | 3.93K | ▲ 18 |
| Pathstone Family Office, LLC | 1.03K | 0 |
| Benjamin F. Edwards & Company, Inc. | 160 | ▲ 160 |
Held by 1 ETFs
Biggest fund positions in ATRI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 21, 24 | STUPP JOHN P JR | sell | 879.12 |
| Aug 21, 24 | STUPP JOHN P JR | sell | 135,000 |
| Aug 21, 24 | Spaulding Ronald Nicholas | sell | 2,678 |
| Aug 21, 24 | Spaulding Ronald Nicholas | sell | 312.51 |
| Aug 21, 24 | Athey Preston G | sell | 312.51 |
| Aug 21, 24 | Athey Preston G | sell | 1,368 |
| Aug 21, 24 | Bankes Jeannette | sell | 312.51 |
| Aug 21, 24 | Bankes Jeannette | sell | 186 |
| Aug 21, 24 | BATTAT EMILE A | sell | 150,616 |
| Aug 21, 24 | BATTAT EMILE A | sell | 310.87 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ATRI coverage
Recent articles, reports, and earnings notes.
No research on ATRI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ATRI report →Is Ares Management (ARES) a Value Opportunity After Q1 2026? GAAP EPS $0.46 (miss vs $1.39 est), Revenue not disclosed; GF Score 83/100, GF Value: 32.5% undervalued
gurufocus.com · May 1
ATRI WELCOMES TWO INDUSTRY LEADERS TO ITS BOARD OF DIRECTORS
prnewswire.com · Nov 4
Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth
investorplace.com · Aug 14
Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs
zacks.com · Aug 9
Atrion Reports Second Quarter 2024 Results
globenewswire.com · Aug 8
ATRI ALERT: The M&A Class Action Firm Investigates the Merger and August 19, 2024 Shareholder Vote of Atrion Corporation
prnewswire.com · Jul 29
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders
accesswire.com · Jul 28
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, HTLF on Behalf of Shareholders
globenewswire.com · Jul 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.